Sei Investments Co. Purchases 7,798 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Sei Investments Co. boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 293,265 shares of the medical device company’s stock after purchasing an additional 7,798 shares during the period. Sei Investments Co.’s holdings in Cooper Companies were worth $26,961,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. American Century Companies Inc. increased its stake in shares of Cooper Companies by 0.9% during the fourth quarter. American Century Companies Inc. now owns 45,210 shares of the medical device company’s stock valued at $4,156,000 after buying an additional 412 shares during the period. Mizuho Securities USA LLC increased its position in Cooper Companies by 46.2% during the 4th quarter. Mizuho Securities USA LLC now owns 18,875 shares of the medical device company’s stock valued at $1,735,000 after purchasing an additional 5,963 shares during the period. Virtu Financial LLC bought a new position in Cooper Companies in the 4th quarter worth $283,000. Blueshift Asset Management LLC purchased a new stake in shares of Cooper Companies in the 4th quarter worth about $696,000. Finally, Magnetar Financial LLC boosted its stake in shares of Cooper Companies by 19.9% during the 4th quarter. Magnetar Financial LLC now owns 708,732 shares of the medical device company’s stock valued at $65,154,000 after purchasing an additional 117,720 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on COO shares. Piper Sandler restated an “overweight” rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Robert W. Baird dropped their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Finally, Citigroup decreased their price target on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Stock Down 0.4 %

NASDAQ:COO opened at $83.70 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $16.74 billion, a P/E ratio of 42.92, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a fifty-two week low of $77.05 and a fifty-two week high of $112.38. The firm has a 50-day simple moving average of $89.80 and a two-hundred day simple moving average of $97.72.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.